Jeevan Scientific Technology Limited secured approval from the Central Drugs Standard Control Organization (CDSCO) for an expanded bed capacity at its Hyderabad Bioavailability/Bioequivalence (BA/BE) Study Centre.

Total beds will increase from 132 to 156, and ICU beds from 6 to 8. This expansion, approved after a successful regulatory inspection, significantly strengthens the company's clinical research infrastructure.

It will enable a higher volume of BA/BE studies, enhancing operational capabilities and paving the way for future business growth for stakeholders.